- Home
- IMMX vs EHGO Comparison
IMMX vs EHGO Comparison
Compare IMMX & EHGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- EHGO
- Stock Information
- Founded
- IMMX 2014
- EHGO 2015
- Country
- IMMX United States
- EHGO China
- Employees
- IMMX N/A
- EHGO N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- EHGO
- Sector
- IMMX Health Care
- EHGO
- Exchange
- IMMX Nasdaq
- EHGO NYSE
- Market Cap
- IMMX 61.1M
- EHGO 91.9M
- IPO Year
- IMMX 2021
- EHGO 2024
- Fundamental
- Price
- IMMX $2.17
- EHGO $3.33
- Analyst Decision
- IMMX Strong Buy
- EHGO
- Analyst Count
- IMMX 1
- EHGO 0
- Target Price
- IMMX $7.00
- EHGO N/A
- AVG Volume (30 Days)
- IMMX 269.5K
- EHGO 580.9K
- Earning Date
- IMMX 11-12-2024
- EHGO 02-15-2025
- Dividend Yield
- IMMX N/A
- EHGO N/A
- EPS Growth
- IMMX N/A
- EHGO N/A
- EPS
- IMMX N/A
- EHGO 0.00
- Revenue
- IMMX N/A
- EHGO $16,963,957.00
- Revenue This Year
- IMMX N/A
- EHGO N/A
- Revenue Next Year
- IMMX $200.00
- EHGO N/A
- P/E Ratio
- IMMX N/A
- EHGO $8,954.67
- Revenue Growth
- IMMX N/A
- EHGO N/A
- 52 Week Low
- IMMX $1.26
- EHGO $1.45
- 52 Week High
- IMMX $7.50
- EHGO $5.50
- Technical
- Relative Strength Index (RSI)
- IMMX 53.37
- EHGO N/A
- Support Level
- IMMX $1.88
- EHGO N/A
- Resistance Level
- IMMX $2.44
- EHGO N/A
- Average True Range (ATR)
- IMMX 0.32
- EHGO 0.00
- MACD
- IMMX -0.02
- EHGO 0.00
- Stochastic Oscillator
- IMMX 34.94
- EHGO 0.00
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About EHGO ESHALLGO INC
Eshallgo Inc. focuses on two distinct market sectors: office supply sale and leasing, and after-sale maintenance and repair. It is an authorized distributor of brands of office equipment, including HP, Epson, Xerox, Sharp, Toshiba, Konica, Kyocera, and other brands.